Yuzhe Shi

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Radical Prostatectomy

Top Venues

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Anton Dobrin, Pieter L Lindenbergh, Yuzhe Shi, Karlo Perica, Hongyao Xie, Nayan Jain, Andrew Chow, Jedd D Wolchok, Taha Merghoub, Michel Sadelain, Mohamad Hamieh
Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies. Nature cancer 5 (5) (2024)
Anton Dobrin, Pieter L Lindenbergh, Yuzhe Shi, Karlo Perica, Hongyao Xie, Nayan Jain, Andrew Chow, Jedd D Wolchok, Taha Merghoub, Michel Sadelain, Mohamad Hamieh
Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies. Nature cancer (2024)
Anton Dobrin, Pieter L Lindenbergh, Yuzhe Shi, Karlo Perica, Hongyao Xie, Nayan Jain, Andrew Chow, Jedd D Wolchok, Taha Merghoub, Michel Sadelain, Mohamad Hamieh
Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies. Nature cancer 5 (5) (2024)
Anton Dobrin, Pieter L Lindenbergh, Yuzhe Shi, Karlo Perica, Hongyao Xie, Nayan Jain, Andrew Chow, Jedd D Wolchok, Taha Merghoub, Michel Sadelain, Mohamad Hamieh
Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies. Nature cancer (2024)
Nayan Jain, Zeguo Zhao, Richard P Koche, Chenling A Xu, Yosi Gozlan, Antonino Montalbano, David Brocks, Michael Lopez, Anton Dobrin, Yuzhe Shi, Gertrude Gunset, Theodoros Giavridis, Michel Sadelain
Disruption of SUV39H1-mediated H3K9 methylation sustains CAR T cell function. Cancer discovery (2023)